Abstract
Platinum complexes have paid much attention to develop new drugs for cancer therapy due to its inhibitory activity against cancerous cell growth. In the study, the strategically programming cationic PAMAM G4.0 with carboxylate motifs was introduced as a delivery platform for cisplatin. Partial amino groups on the surface of PAMAM G4.0 had coupled with active carboxylate groups on polyacrylic acid (PAA) in order to reduce the remaining problem of cationic dendrimer and improve delivery effectiveness of aquated cisplatin. Our results show that the full cationic PAMAM G4.0 was toxic against both breast cancer (MCF7) and human dermal fibroblast (HuDF) cell lines at 100 ppm concentration. In the contract, the PAA-conjugated PAMAM G4.0 significantly improved their cytocompatibility of the cationic dendrimer. In addition, the modified PAMAM dendrimers G4.0 showed high affinity with the aquated cisplatin due to the presence of abundant carboxylic groups. Notably, the aquated cisplatin-complexed PAA-G4.0 showed 2.94-folded reduction in the toxicity against NCI H460 in comparison to free cisplatin drugs. Hence, the G4.0-PAA/aquated cisplatin nano-complex may become a promising versatile strategy for improving antitumour efficacy and reducing the side effects of platinum-based drugs.
Similar content being viewed by others
References
Dasari S and Tchounwou P B 2015 Eur. J. Pharmacol. 740 364
Zhou Z, Hu Y, Shan X, Li W, Bai X, Wang P et al 2015 Sci. Rep. 5 11868
Tong N A N, Nguyen T P, Nguyen C K and Tran N Q 2016 J. Biomater. Sci. Polym. Edt. 27 709
Wagner J M and Karnitz L M 2009 Mol. Pharmacol. 76 208
Shi M, McMillan K L, Wu J, Gillings N, Flores B, Moe O W et al 2018 Lab. Invest. 98 1105
Song Z, Chang H, Han N, Liu Z, Liu Y, Wang H et al 2017 RCS Adv. 7 19794
Sheth S, Mukherjea D, Rybak L P and Ramkumar V 2017 Front. Cell. Neurosci. 11 338
Hai H, Wu T, Shi H, Wu Y, Yang H, Zhong K et al 2019 Chem. Commun. 55 5175
Weiss R B and Christian M C 1993 Drugs 46 360
Nguyen H, Nguyen C K, Nguyen N H and Tran N Q 2015 J. Nanosci. Nanotechnol. 16 4106
Browning R J, Reardon P J T, Parhizkar M, Pedley B, Edirisinghe M, Knowles J C et al 2017 ACS Nano 11 8560
Kirkpatrick G J, Plumb J A, Sutcliffe O B, Flint D J and Wheate N J 2011 J. Inorg. Biochem. 105 1115
Siemann D W 2011 Cancer Treat. Rev. 37 63
Le P N, Nguyen N H, Nguyen C K and Tran N Q 2016 Bull. Mater. Sci. 39 1493
Vu M T, Bach L G, Nguyen D C, Ho M N, Nguyen N H, Tran N Q et al 2019 Int. J. Mol. Sci. 20 2016
Ly T U, Tran N Q, Hoang T K D, Phan K N, Truong T C N and Nguyen C K 2013 J. Biomed. Nanotechnol. 9 213
Nguyen N T, Nguyen N N T, Tran N T N, Le P N, Nguyen T B T, Nguyen N H et al 2018 Molecules 23 3347
Aryal S, Hu C M and Zhang L 2009 ACS Nano 4 251
Abderrezak A, Bourassa P, Mandeville J S, Sedaghat-Herati R and Tajmir-Riahi HA 2012 PLoS ONE 7 e33102
Kulhari H, Pooja D, Singh M K and Chauhan A S 2015 Drug Dev. Ind. Pharm. 41 232
Kaminskas L M, Boyd B J and Porter C J H 2011 Nanomedicine 6 1063
Chandra S, Sascha D, Heinrich L and Dhirendra B 2011 J. Mater. Chem. 21 5729
Bodewein L, Frank S, Stefano D F, Henner H, Rainer F and Martina F 2016 Toxicol. Appl. Pharmacol. 305 83
Chen J, Hessler J A, Putchakayala K, Panama B K, Khan D P, Hong S et al 2009 J. Phys. Chem. B 113 11179
Farshbaf M, Davaran S, Zarebkohan A, Annabi N, Akbarzadeh A and Salehi R 2018 Biotechnology 46 1872
Kapp T, Anja D and Ronald G 2010 Bioconj. Chem. 21 328
Ho M N, Bach L G, Nguyen D H, Nguyen C H, Nguyen C K, Tran N Q et al 2019 Biopolymers 110 e23272
Labieniec-Watala M and Cezary W 2015 J. Pharm. Sci. 104 2
Ye L, Letchford K, Heller M, Liggins R, Guan D, Kizhakkedathu J N et al 2011 Biomacromolecules 12 145
Li H J, Du J Z, Du X J, Xu C F, Sun C Y, Wang H X et al 2016 PNAS 113 4164
Nguyen T B T, Nguyen T T C, Tran N Q and Nguyen C K 2015 Int. J. Polym. Anal. Charact. 20 57
Stoyanova E, Petrov P, Karadjova I, Momekov G and Koseva N 2017 Polym. J. 49 607
Ding D, Wang J, Zhu Z, Li R, Wu W, Liu B et al 2012 ACS Appl. Mater. Interfaces 4 1838
Surnar B, Sharma K and Jayakannan M 2012 Nanoscale 7 17964
Acknowledgements
This research was funded by Thu Dau Mot University, under grant number 487/HD-NCKHPTCN. We are grateful to the group of Department of Genetics, Faculty of Biology, University of Science, for providing cancer cell line (MCF7 cells and NCI H460 cells) and human fibroblast cells (HuDF).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nguyen, N.H., Dang, L.H., Doan, P. et al. Polyacrylic-conjugated polyamidoamine G4.0 dendrimer as a potential nanocarrier for effective delivery of cisplatin. Bull Mater Sci 44, 87 (2021). https://doi.org/10.1007/s12034-021-02382-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12034-021-02382-w